JAK–STAT pathway targeting for the treatment of inflammatory bowel disease

A Salas, C Hernandez-Rocha, M Duijvestein… - Nature reviews …, 2020 - nature.com
Cytokines are involved in intestinal homeostasis and pathological processes associated
with inflammatory bowel disease (IBD). The biological effects of cytokines, including several …

Fluorine-containing drugs approved by the FDA in 2019

H Mei, AM Remete, Y Zou, H Moriwaki, S Fustero… - Chinese Chemical …, 2020 - Elsevier
Eleven new fluorine-containing FDA-approved drugs have been profiled and details of their
discovery and preparation are discussed. Therapeutic areas include schizophrenia …

[HTML][HTML] Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis

JG Krueger, IB McInnes, A Blauvelt - Journal of the American Academy of …, 2022 - Elsevier
Plaque psoriasis is a common, chronic, systemic, immune-mediated inflammatory disease.
The Janus kinase-signal transducer and activator of transcription pathway plays a major role …

Emerging pharmacotherapy for inflammatory bowel diseases

H Luo, G Cao, C Luo, D Tan, CT Vong, Y Xu… - Pharmacological …, 2022 - Elsevier
Inflammatory bowel disease (IBD) refers to a gamut of disorders that are characterized by
chronic intestinal inflammation, including ulcerative colitis (UC) and Crohn's disease (CD) …

Targeting sphingosine-1-phosphate signaling in immune-mediated diseases: beyond multiple sclerosis

T Pérez-Jeldres, M Alvarez-Lobos, J Rivera-Nieves - Drugs, 2021 - Springer
Abstract Sphingosine-1-phosphate (S1P) is a bioactive lipid metabolite that exerts its actions
by engaging 5 G-protein-coupled receptors (S1PR1-S1PR5). S1P receptors are involved in …

Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target

OA Sukocheva, H Furuya, ML Ng, M Friedemann… - Pharmacology & …, 2020 - Elsevier
Inflammatory gastrointestinal (GI) diseases and malignancies are associated with growing
morbidity and cancer-related mortality worldwide. GI tumor and inflammatory cells contain …

Tyk2 targeting in immune-mediated inflammatory diseases

L Rusiñol, L Puig - International journal of molecular sciences, 2023 - mdpi.com
The Janus kinase (Jak)/signal transducer and activating protein (STAT) pathways mediate
the intracellular signaling of cytokines in a wide spectrum of cellular processes. They …

Type 2 inflammation in eosinophilic esophagitis: from pathophysiology to therapeutic targets

F Racca, G Pellegatta, G Cataldo, E Vespa… - Frontiers in …, 2022 - frontiersin.org
Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease of the esophagus
characterized clinically by symptoms related to esophageal dysfunction and histologically by …

Astragaloside IV alleviates the experimental DSS-induced colitis by remodeling macrophage polarization through STAT signaling

L Tian, JL Zhao, JQ Kang, S Guo, N Zhang… - Frontiers in …, 2021 - frontiersin.org
Inflammatory bowel disease (IBD) is characterized by chronic and relapsing intestinal
inflammation, which currently lacks safe and effective medicine. Some previous studies …

[HTML][HTML] Selective JAK1 inhibitors for the treatment of inflammatory bowel disease

OH Nielsen, TL Boye, J Gubatan, D Chakravarti… - Pharmacology & …, 2023 - Elsevier
Janus kinase (JAK) inhibitors, also known as jakinibs, are third-generation oral small
molecules that have expanded the therapeutic options for the management of chronic …